BridgeBio Pharma BBIO Distributions to noncontrolling interests
Distributions to noncontrolling interests at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsToMinorityShareholders.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's distributions to noncontrolling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's distributions to noncontrolling interests?
- BridgeBio Pharma (BBIO) reported distributions to noncontrolling interests of $0 in Q1 2026.
- How has BridgeBio Pharma's distributions to noncontrolling interests changed year-over-year?
- BridgeBio Pharma's distributions to noncontrolling interests decreased by 100.0% year-over-year, from $800K to $0.
- What does distributions to noncontrolling interests mean?
- Cash paid to minority partners in consolidated business units.
- How do you interpret distributions to noncontrolling interests?
- Changes reflect the profitability and dividend policies of the specific subsidiaries held by the parent company.
- How does distributions to noncontrolling interests compare across companies?
- Depends on the structure of joint ventures and subsidiary ownership percentages.